| 1 | Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates | 38.2 | 8 | Citations (PDF) |
| 2 | Affinity gaps among B cells in germinal centers drive the selection of MPER precursors | 13.1 | 4 | Citations (PDF) |
| 3 | Vaccination induces broadly neutralizing antibody precursors to HIV gp41 | 13.1 | 7 | Citations (PDF) |
| 4 | Priming antibody responses to the fusion peptide in rhesus macaques | 5.8 | 0 | Citations (PDF) |
| 5 | Immunological memory diversity in the human upper airway | 40.1 | 14 | Citations (PDF) |
| 6 | The transcription factor Mef2d regulates B:T synapse–dependent GC-T
<sub>FH</sub>
differentiation and IL-21–mediated humoral immunity | 14.0 | 8 | Citations (PDF) |
| 7 | The Chromatin Regulator Mll1 Supports T Follicular Helper Cell Differentiation by Controlling Expression of Bcl6, LEF-1, and TCF-1 | 0.6 | 4 | Citations (PDF) |
| 8 | Transcriptional programming of CD4
<sup>+</sup>
T
<sub>RM</sub>
differentiation in viral infection balances effector- and memory-associated gene expression | 14.0 | 3 | Citations (PDF) |
| 9 | A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates | 14.1 | 4 | Citations (PDF) |
| 10 | Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature | 5.6 | 93 | Citations (PDF) |
| 11 | From structure to sequence: Antibody discovery using cryoEM | 11.3 | 22 | Citations (PDF) |
| 12 | SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to OmicronCell, 2022, 185, 847-859.e11 | 35.1 | 593 | Citations (PDF) |
| 13 | Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status | 15.2 | 28 | Citations (PDF) |
| 14 | Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer | 6.4 | 5 | Citations (PDF) |
| 15 | Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | 5.6 | 10 | Citations (PDF) |
| 16 | Humoral and cellular immune memory to four COVID-19 vaccinesCell, 2022, 185, 2434-2451.e17 | 35.1 | 339 | Citations (PDF) |
| 17 | Correlates of protection against <scp>SARS</scp>‐<scp>CoV</scp>‐2 infection and COVID‐19 disease | 6.8 | 175 | Citations (PDF) |
| 18 | Immunological memory to <scp>SARS‐CoV</scp>‐2 infection and <scp>COVID</scp>‐19 vaccines | 6.8 | 178 | Citations (PDF) |
| 19 | NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses | 9.1 | 34 | Citations (PDF) |
| 20 | Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques | 13.1 | 15 | Citations (PDF) |
| 21 | Long-primed germinal centres with enduring affinity maturation and clonal migration | 40.1 | 94 | Citations (PDF) |
| 22 | The Transcription Factor YY-1 Is an Essential Regulator of T Follicular Helper Cell Differentiation | 0.6 | 1 | Citations (PDF) |
| 23 | Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses | 5.5 | 6 | Citations (PDF) |
| 24 | Vaccination induces HIV broadly neutralizing antibody precursors in humans | 38.2 | 122 | Citations (PDF) |
| 25 | HIV vaccinology: 2021 update | 6.5 | 32 | Citations (PDF) |
| 26 | Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | 38.2 | 1,953 | Citations (PDF) |
| 27 | Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases | 7.3 | 360 | Citations (PDF) |
| 28 | Adaptive immunity to SARS-CoV-2 and COVID-19 | 35.1 | 1,322 | Citations (PDF) |
| 29 | Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH) | 15.9 | 104 | Citations (PDF) |
| 30 | Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers | 4.0 | 54 | Citations (PDF) |
| 31 | Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection | 8.1 | 22 | Citations (PDF) |
| 32 | AI-guided discovery of the invariant host response to viral pandemics | 10.0 | 35 | Citations (PDF) |
| 33 | SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19 | 15.2 | 216 | Citations (PDF) |
| 34 | Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals | 7.3 | 445 | Citations (PDF) |
| 35 | Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates | 4.5 | 16 | Citations (PDF) |
| 36 | Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM | 14.1 | 39 | Citations (PDF) |
| 37 | Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells | 5.8 | 43 | Citations (PDF) |
| 38 | Revealing T follicular helper cells with BCL6 | 17.9 | 5 | Citations (PDF) |
| 39 | Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | 38.2 | 238 | Citations (PDF) |
| 40 | Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers | 8.1 | 30 | Citations (PDF) |
| 41 | Multiplexed CRISPR/CAS9‐mediated engineering of pre‐clinical mouse models bearing native human B cell receptors | 7.4 | 29 | Citations (PDF) |
| 42 | SARS-CoV-2 infection generates tissue-localized immunological memory in humans | 14.0 | 146 | Citations (PDF) |
| 43 | A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity | 14.0 | 78 | Citations (PDF) |
| 44 | Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2 | 11.3 | 22 | Citations (PDF) |
| 45 | Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo | 22.7 | 141 | Citations (PDF) |
| 46 | Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020, 183, 996-1012.e19 | 35.1 | 1,341 | Citations (PDF) |
| 47 | Cross-reactive memory T cells and herd immunity to SARS-CoV-2 | 17.9 | 193 | Citations (PDF) |
| 48 | Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults | 5.0 | 14 | Citations (PDF) |
| 49 | Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans | 38.2 | 833 | Citations (PDF) |
| 50 | B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models | 7.7 | 39 | Citations (PDF) |
| 51 | Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations | 5.8 | 42 | Citations (PDF) |
| 52 | Factors in B cell competition and immunodominance | 6.8 | 59 | Citations (PDF) |
| 53 | Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits | 13.1 | 87 | Citations (PDF) |
| 54 | 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates | 14.0 | 94 | Citations (PDF) |
| 55 | Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers | 5.0 | 3 | Citations (PDF) |
| 56 | Pre-existing immunity to SARS-CoV-2: the knowns and unknowns | 17.9 | 265 | Citations (PDF) |
| 57 | Engineered immunogen binding to alum adjuvant enhances humoral immunity | 25.6 | 176 | Citations (PDF) |
| 58 | Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations | 1.5 | 31 | Citations (PDF) |
| 59 | Reinvigorating NIH Grant Peer Review | 22.7 | 14 | Citations (PDF) |
| 60 | Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020, 181, 1489-1501.e15 | 35.1 | 2,714 | Citations (PDF) |
| 61 | A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses | 38.2 | 153 | Citations (PDF) |
| 62 | Editorial overview: Vaccine immunology: what is seen and not seen | 5.6 | 2 | Citations (PDF) |
| 63 | Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of ImmunodominanceCell, 2019, 177, 1153-1171.e28 | 35.1 | 290 | Citations (PDF) |
| 64 | T Follicular Helper Cell Biology: A Decade of Discovery and Diseases | 22.7 | 978 | Citations (PDF) |
| 65 | Recurrent group A
<i>Streptococcus</i>
tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant T
<sub>FH</sub>
cells | 13.1 | 85 | Citations (PDF) |
| 66 | Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers | 22.7 | 118 | Citations (PDF) |
| 67 | The Transcription Factor Runx3 Establishes Chromatin Accessibility of cis-Regulatory Landscapes that Drive Memory Cytotoxic T Lymphocyte Formation | 22.7 | 120 | Citations (PDF) |
| 68 | Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens | 22.7 | 240 | Citations (PDF) |
| 69 | Raging evolution of a B cell response to a viral infection | 17.9 | 4 | Citations (PDF) |
| 70 | BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data | 9.9 | 51 | Citations (PDF) |
| 71 | Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets | 2.3 | 4 | Citations (PDF) |
| 72 | Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis | 14.1 | 132 | Citations (PDF) |
| 73 | Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? | 7.4 | 46 | Citations (PDF) |
| 74 | Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells | 2.8 | 47 | Citations (PDF) |
| 75 | Structure–function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8 | 2.3 | 23 | Citations (PDF) |
| 76 | Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf | 14.1 | 57 | Citations (PDF) |
| 77 | When designing vaccines, consider the starting material: the human B cell repertoire | 5.6 | 50 | Citations (PDF) |
| 78 | The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen | 13.1 | 97 | Citations (PDF) |
| 79 | Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b | 14.1 | 54 | Citations (PDF) |
| 80 | Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials | 3.2 | 9 | Citations (PDF) |
| 81 | Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques | 4.5 | 84 | Citations (PDF) |
| 82 | Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters | 9.1 | 93 | Citations (PDF) |
| 83 | Tfh cells and <scp>HIV</scp> bnAbs, an immunodominance model of the <scp>HIV</scp> neutralizing antibody generation problem | 6.8 | 138 | Citations (PDF) |
| 84 | Development of an animal model of progressive vaccinia in nu/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteins | 3.9 | 2 | Citations (PDF) |
| 85 | Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches | 22.7 | 252 | Citations (PDF) |
| 86 | Epigenetic landscapes reveal transcription factors that regulate CD8+ T cell differentiation | 13.1 | 176 | Citations (PDF) |
| 87 | Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques | 3.6 | 72 | Citations (PDF) |
| 88 | Germinal center enhancement by extended antigen availability | 5.6 | 90 | Citations (PDF) |
| 89 | Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding | 14.1 | 120 | Citations (PDF) |
| 90 | A distinct subpopulation of CD25<sup>−</sup>T-follicular regulatory cells localizes in the germinal centers | 7.7 | 152 | Citations (PDF) |
| 91 | Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses | 2.5 | 42 | Citations (PDF) |
| 92 | Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells | 2.5 | 208 | Citations (PDF) |
| 93 | Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours | 40.1 | 462 | Citations (PDF) |
| 94 | T cells control the generation of nanomolar-affinity anti-glycan antibodies | 9.1 | 64 | Citations (PDF) |
| 95 | Activin A programs the differentiation of human TFH cells | 13.1 | 124 | Citations (PDF) |
| 96 | Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood | 2.5 | 67 | Citations (PDF) |
| 97 | IL-2 Mediates Generalized Tfh Downregulation during Allergen-Specific Immunotherapy | 2.8 | 0 | Citations (PDF) |
| 98 | Id2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation | 13.1 | 88 | Citations (PDF) |
| 99 | Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox | 3.6 | 26 | Citations (PDF) |
| 100 | A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1 | 13.1 | 58 | Citations (PDF) |
| 101 | Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination | 7.7 | 283 | Citations (PDF) |
| 102 | Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer | 6.4 | 136 | Citations (PDF) |
| 103 | Response to Comment on “A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood” | 0.6 | 7 | Citations (PDF) |
| 104 | Dances with cytokines, featuring TFH cells, IL-21, IL-4 and B cells | 13.1 | 48 | Citations (PDF) |
| 105 | A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood | 0.6 | 189 | Citations (PDF) |
| 106 | Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique | 0.6 | 107 | Citations (PDF) |
| 107 | CXCL13 is a plasma biomarker of germinal center activity | 7.7 | 269 | Citations (PDF) |
| 108 | Cutting Edge: NFAT Transcription Factors Promote the Generation of Follicular Helper T Cells in Response to Acute Viral Infection | 0.6 | 59 | Citations (PDF) |
| 109 | CRISPR-Mediated Slamf1Δ/Δ Slamf5Δ/Δ Slamf6Δ/Δ Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects | 2.5 | 14 | Citations (PDF) |
| 110 | Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort | 4.5 | 205 | Citations (PDF) |
| 111 | Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection | 0.6 | 61 | Citations (PDF) |
| 112 | Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesCell, 2015, 163, 1702-1715 | 35.1 | 281 | Citations (PDF) |
| 113 | A brief history of T cell help to B cells | 17.9 | 420 | Citations (PDF) |
| 114 | The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells | 22.7 | 556 | Citations (PDF) |
| 115 | Dengue virus infection elicits highly polarized CX3CR1<sup>+</sup>cytotoxic CD4<sup>+</sup>T cells associated with protective immunity | 7.7 | 227 | Citations (PDF) |
| 116 | LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6 | 13.1 | 259 | Citations (PDF) |
| 117 | Cutting Edge: T Follicular Helper Cell Differentiation Is Defective in the Absence of Bcl6 BTB Repressor Domain Function | 0.6 | 26 | Citations (PDF) |
| 118 | In vivo RNAi screens: concepts and applications | 15.9 | 15 | Citations (PDF) |
| 119 | BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms | 8.1 | 200 | Citations (PDF) |
| 120 | Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity | 3.6 | 129 | Citations (PDF) |
| 121 | Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3 | 7.7 | 30 | Citations (PDF) |
| 122 | Retroviral Vector Expression in TCR Transgenic CD4+ T Cells | 0.0 | 7 | Citations (PDF) |
| 123 | Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer | 4.5 | 36 | Citations (PDF) |
| 124 | Ribavirin's antiviral mechanism of action: lethal mutagenesis? | 3.6 | 132 | Citations (PDF) |
| 125 | Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein | 3.6 | 42 | Citations (PDF) |
| 126 | Murine Anti-vaccinia Virus D8 Antibodies Target Different Epitopes and Differ in Their Ability to Block D8 Binding to CS-E | 4.5 | 17 | Citations (PDF) |
| 127 | Early Lymphoid Responses and Germinal Center Formation Correlate with Lower Viral Load Set Points and Better Prognosis of Simian Immunodeficiency Virus Infection | 0.6 | 37 | Citations (PDF) |
| 128 | Using a Combined Computational-Experimental Approach to Predict Antibody-Specific B Cell Epitopes | 3.9 | 56 | Citations (PDF) |
| 129 | T Follicular Helper Cell Differentiation, Function, and Roles in Disease | 22.7 | 1,394 | Citations (PDF) |
| 130 | The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells | 13.1 | 96 | Citations (PDF) |
| 131 | The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells | 13.1 | 104 | Citations (PDF) |
| 132 | In Vivo RNA Interference Screens Identify Regulators of Antiviral CD4+ and CD8+ T Cell Differentiation | 22.7 | 91 | Citations (PDF) |
| 133 | BCL6 Orchestrates Tfh Differentiation Via Multiple Distinct MechanismsBlood, 2014, 124, 4137-4137 | 1.0 | 1 | Citations (PDF) |
| 134 | Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses | 22.7 | 704 | Citations (PDF) |
| 135 | Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells | 5.6 | 80 | Citations (PDF) |
| 136 | S-4 | 3.5 | 0 | Citations (PDF) |
| 137 | Exogenous OX40 Stimulation during Lymphocytic Choriomeningitis Virus Infection Impairs Follicular Th Cell Differentiation and Diverts CD4 T Cells into the Effector Lineage by Upregulating Blimp-1 | 0.6 | 33 | Citations (PDF) |
| 138 | Harnessing CD4+ T cell responses in HIV vaccine development | 25.6 | 81 | Citations (PDF) |
| 139 | Cutting Edge: STAT1 Is Required for IL-6–Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation | 0.6 | 247 | Citations (PDF) |
| 140 | Inadequate T follicular cell help impairs B cell immunity during HIV infection | 25.6 | 321 | Citations (PDF) |
| 141 | Modulation of SAP dependent T:B cell interactions as a strategy to improve vaccination | 5.2 | 42 | Citations (PDF) |
| 142 | Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine | 3.6 | 24 | Citations (PDF) |
| 143 | Bcl6 Expressing Follicular Helper CD4 T Cells Are Fate Committed Early and Have the Capacity To Form Memory | 0.6 | 192 | Citations (PDF) |
| 144 | Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5 | 3.6 | 33 | Citations (PDF) |
| 145 | Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation | 0.6 | 286 | Citations (PDF) |
| 146 | STAT5 is a potent negative regulator of TFH cell differentiation | 8.1 | 405 | Citations (PDF) |
| 147 | OX40 Facilitates Control of a Persistent Virus Infection | 4.5 | 59 | Citations (PDF) |
| 148 | The Receptor Ly108 Functions as a SAP Adaptor-Dependent On-Off Switch for T Cell Help to B Cells and NKT Cell Development | 22.7 | 133 | Citations (PDF) |
| 149 | A Blueprint for HIV Vaccine Discovery | 15.2 | 327 | Citations (PDF) |
| 150 | Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies | 2.5 | 20 | Citations (PDF) |
| 151 | The 1‐1‐1 fallacy | 6.8 | 30 | Citations (PDF) |
| 152 | Follicular Helper CD4 T Cells (T<sub>FH</sub>) | 30.9 | 2,227 | Citations (PDF) |
| 153 | Protective Murine and Human Monoclonal Antibodies against Eczema Vaccinatum | 2.1 | 10 | Citations (PDF) |
| 154 | IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation | 2.5 | 418 | Citations (PDF) |
| 155 | An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies | 2.3 | 20 | Citations (PDF) |
| 156 | ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6 | 22.7 | 754 | Citations (PDF) |
| 157 | B Cell-Specific Expression of B7-2 Is Required for Follicular Th Cell Function in Response to Vaccinia Virus | 0.6 | 63 | Citations (PDF) |
| 158 | Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation | 13.1 | 419 | Citations (PDF) |
| 159 | Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model | 2.1 | 51 | Citations (PDF) |
| 160 | In Vivo Regulation of Bcl6 and T Follicular Helper Cell Development | 0.6 | 233 | Citations (PDF) |
| 161 | Germinal Center T Follicular Helper Cell IL-4 Production Is Dependent on Signaling Lymphocytic Activation Molecule Receptor (CD150) | 0.6 | 346 | Citations (PDF) |
| 162 | Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage | 0.1 | 15 | Citations (PDF) |
| 163 | Uncovering the Interplay Between CD8, CD4 and Antibody Responses to Complex Pathogens | 2.0 | 59 | Citations (PDF) |
| 164 | Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum | 8.1 | 69 | Citations (PDF) |
| 165 | Shane Crotty: Exploring immune memory | 8.1 | 1 | Citations (PDF) |
| 166 | Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement | 3.6 | 97 | Citations (PDF) |
| 167 | Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5 | 3.6 | 55 | Citations (PDF) |
| 168 | The smallpox vaccine induces an early neutralizing IgM response | 3.2 | 29 | Citations (PDF) |
| 169 | Definition of epitopes and antigens recognized by vaccinia specific immune responses: Their conservation in variola virus sequences, and use as a model system to study complex pathogens | 3.2 | 40 | Citations (PDF) |
| 170 | Selective CD4+ T Cell Help for Antibody Responses to a Large Viral Pathogen: Deterministic Linkage of Specificities | 22.7 | 155 | Citations (PDF) |
| 171 | Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo | 1.7 | 95 | Citations (PDF) |
| 172 | OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells | 0.6 | 68 | Citations (PDF) |
| 173 | NKT cells prevent chronic joint inflammation after infection with<i>Borrelia burgdorferi</i> | 7.7 | 85 | Citations (PDF) |
| 174 | Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine | 3.6 | 92 | Citations (PDF) |
| 175 | T cell independent B cell response to an RNA‐binding viral protein (Vaccinia E3) | 0.7 | 0 | Citations (PDF) |
| 176 | Important roles for Fyn in CD4 T cell activation and helper functions in vivo | 0.7 | 0 | Citations (PDF) |
| 177 | Protection from vaccinia virus‐induced severe skin lesions by natural killer cells in a mouse model of eczema vaccinatum | 0.7 | 0 | Citations (PDF) |
| 178 | Chronic Lymphocytic Choriomeningitis Virus Infection Actively Down-Regulates CD4+ T Cell Responses Directed against a Broad Range of Epitopes | 0.6 | 25 | Citations (PDF) |
| 179 | Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses | 0.6 | 87 | Citations (PDF) |
| 180 | SAP Regulation of Follicular Helper CD4 T Cell Development and Humoral Immunity Is Independent of SLAM and Fyn Kinase | 0.6 | 91 | Citations (PDF) |
| 181 | Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection | 3.5 | 122 | Citations (PDF) |
| 182 | Proteome-wide analysis of the serological response to vaccinia and smallpox | 3.8 | 134 | Citations (PDF) |
| 183 | Ly9 (CD229)-Deficient Mice Exhibit T Cell Defects yet Do Not Share Several Phenotypic Characteristics Associated with SLAM- and SAP-Deficient Mice | 0.6 | 89 | Citations (PDF) |
| 184 | Hypogammaglobulinemia and exacerbated CD8 T-cell–mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP diseaseBlood, 2006, 108, 3085-3093 | 1.0 | 42 | Citations (PDF) |
| 185 | Immunity and immunological memory following smallpox vaccination | 6.8 | 181 | Citations (PDF) |
| 186 | SAP regulates T cell–mediated help for humoral immunity by a mechanism distinct from cytokine regulation | 8.1 | 136 | Citations (PDF) |
| 187 | Resolution of a chronic viral infection after interleukin-10 receptor blockade | 8.1 | 474 | Citations (PDF) |
| 188 | Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice | 3.6 | 188 | Citations (PDF) |
| 189 | Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery | 7.7 | 348 | Citations (PDF) |
| 190 | The Poliovirus Replication Machinery Can Escape Inhibition by an Antiviral Drug That Targets a Host Cell Protein | 3.6 | 50 | Citations (PDF) |
| 191 | Immune Responses toBacillus anthracisProtective Antigen in Patients with Bioterrorism‐Related Cutaneous or Inhalation Anthrax | 4.0 | 116 | Citations (PDF) |
| 192 | Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system | 1.5 | 367 | Citations (PDF) |
| 193 | Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine | 15.7 | 34 | Citations (PDF) |
| 194 | Immunological memory in humans | 6.5 | 186 | Citations (PDF) |
| 195 | SAP is required for generating long-term humoral immunity | 40.1 | 366 | Citations (PDF) |
| 196 | Manganese-Dependent Polioviruses Caused by Mutations within the Viral Polymerase | 3.6 | 22 | Citations (PDF) |
| 197 | Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination | 0.6 | 550 | Citations (PDF) |
| 198 | Virus-based vectors for gene expression in mammalian cells: Poliovirus | 0.0 | 0 | Citations (PDF) |
| 199 | Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin | 2.4 | 77 | Citations (PDF) |
| 200 | Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection | 3.5 | 66 | Citations (PDF) |
| 201 | Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors | 3.6 | 93 | Citations (PDF) |
| 202 | Ahead of the Curve 2001, , | | 13 | Citations (PDF) |
| 203 | The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen | 25.6 | 709 | Citations (PDF) |
| 204 | Poliovirus RNA-dependent RNA Polymerase (3Dpol) | 2.3 | 105 | Citations (PDF) |
| 205 | Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen | 40.1 | 112 | Citations (PDF) |
| 206 | Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen | 40.1 | 505 | Citations (PDF) |
| 207 | Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity | 3.6 | 71 | Citations (PDF) |
| 208 | Immunological Memory 0, , | | 0 | Citations (PDF) |
